This edition of Compliance Checkpoints is designed to help you evaluate the various technology service providers who offer Patient Protection and Affordable Care Act (“PPACA”) compliance and reporting solutions.
1 - 10 of 89 items [Currently showing All Items in Healthcare]
Pharmacy benefit managers (PBMs) and specialty pharmacies can vary in the quality of clinical services provided in managing patients, who have complex medical conditions and receive high cost medications.
Do unwelcome behaviors exist in your workplace environment? If so, is the elephant in the room ignored or acknowledged? In light of all of the attention on sexual harassment brought by the #metoo movement, this seems an opportune time to examine this dilemma in the healthcare industry.
As a trusted advisor, Gallagher will help you navigate the ever-changing landscape of employee benefits compliance issues. This edition of Compliance Checkpoints highlights workable strategies that organizations have implemented to assist employees and their family members with opioid addiction, which is an epidemic in the United States. Below, we explain how the right benefit plan can be your prescription for a better workplace.
The market is always fluctuating, and though some anticipated a significant market tightening in 2018 as a result of the catastrophic events that occurred at the end of 2017, the threat of a near term correction has largely dissipated.
Recently, the U.S. Court of Appeals for the Second Circuit, applying New York law, and the U.S. Court of Appeals for the Sixth Circuit, applying Michigan law, respectively, agreed with an insured that the computer fraud provisions of a crime policy covered the loss incurred when the company’s employees transferred funds in response to a spoofed email.
At annual enrollment HR must communicate with employees and complete a variety of administrative activities in a very short time. Our 1-hour recorded webinar is designed to help HR professionals with this year’s annual enrollment process.
This market update will identify and evaluate factors contributing to market conditions and detail the state of the current market and future expectations for public company D&O.
Artificial Intelligence (AI) and Intelligence Augmentation (IA) in healthcare are hot topics, and they are gaining strides in the quest to use data to improve medical treatment. Although AI and IA are closely related, in this newsletter I will use the term AI to encompass both technologies.
The purpose of this paper is to explain the basis of liability for a public company, discuss the D&O marketplace with respect to IPO exposures, and set forth what you can expect from us as your broker in the process.